Shraddha Subramanian

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Magnetic Resonance

Metastatic Breast Cancer

Top Venues

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S Carmon
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 16 (7) (2024)
Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S Carmon
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 16 (7) (2024)
Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S Carmon
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases. Pharmaceutics 16 (7) (2024)
Tressie A Posey, Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E Francisco, Zhengdong Liang, Kendra S Carmon
Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells. Molecular cancer therapeutics (2023)
Shraddha Subramanian, Alexes C Daquinag, Solmaz AghaAmiri, Sukhen C Ghosh, Ali Azhdarinia, Mikhail G Kolonin
Characterization of Peptides Targeting Metastatic Tumor Cells as Probes for Cancer Detection and Vehicles for Therapy Delivery. Cancer research 81 (22) (2021)